Researchers have developed a pump that recreates the pulsatile blood flow patterns of the human heart within lab-on-a-chip systems, overcoming a quarter-century limitation in organ-modeling technology. The design draws inspiration from accordion mechanics to generate realistic heartbeat rhythms in miniature artificial environments containing human cells.
Lab-on-a-chip devices, also known as microphysiological systems, have enabled scientists to study disease mechanisms and test drug candidates using actual human cells in controlled settings. These platforms model everything from cardiovascular function to organ toxicity. Yet the technology has consistently failed to replicate the dynamic, pulsing blood flow that the human heart naturally produces. Most existing systems use steady, constant flow that bears little resemblance to biological conditions.
This accordion-inspired pump addresses that gap by mechanically recreating the characteristic waveforms of cardiac output. The accordion's expanding and contracting motion translates into a device that generates pulsatile flow matching human hemodynamics. This development removes a critical barrier that has restricted the accuracy of disease modeling and drug testing on chips.
The pump's ability to match real heartbeat patterns should improve how well lab-on-a-chip systems predict drug responses and toxicity in human patients. Current steady-flow systems may miss important biological responses triggered specifically by pulsatile forces acting on cells. Endothelial cells lining blood vessels, for instance, respond differently to constant versus pulsating shear stress.
The accordion-inspired mechanism represents clever biomimetic engineering. Rather than complex electronic controllers or pneumatic systems, the design leverages mechanical principles to achieve physiological accuracy with relative simplicity.
This innovation extends the utility of microphysiological systems for personalized medicine and pharmaceutical development. By more accurately replicating human cardiovascular physiology, researchers can better predict whether experimental drugs will work safely and effectively in patients. The technology